Hims & Hers Health, Inc.(HIMS)
NASDAQ

Company Profile & Information

$32.84
-0.84 (-2.49%)

Company Profile

Business overview, scale, and footprint

Company NameHims & Hers Health, Inc.
Ticker SymbolHIMS
ExchangeNYQ
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees2,442
CEOMr. Andrew Dudum
FoundedN/A
HeadquartersSan Francisco, CA, United States
CountryUnited States
Websitehims.com
Next Earnings DateMay 11, 2026

Business Overview

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.

Insider Transactions

Open-market activity and option exercises

Insider Activity Summary

Insider trading activity for Hims & Hers Health, Inc. (HIMS) over the last 3 months consists of 153 total transactions. Among these, company executives and board members conducted 153 buys (totaling 13,163,465 shares) and 0 sells (totaling 0 shares). This activity resulted in a net change of 13,163,465 shares, reflecting net buying interest with an estimated net acquisitions value of $3.20B.

153 insider transactions found. Showing 10 of 153 transactions.

Show:entries
Insider NameRelation to CompanyShares ChangedPriceTransaction Date
OKUPE OLUYEMIChief Financial Officer18,197$0.62Jun 22, 2026
OKUPE OLUYEMIChief Financial Officer6,376$31944.00Jun 22, 2026
CARROLL PATRICK HARRISONOfficer23,726$0.83Jun 18, 2026
CHI MICHAEL YChief Operating Officer14,027$0.44Jun 17, 2026
ELSHENAWY MOHAMEDChief Technology Officer30,040$0.95Jun 17, 2026
BECKLUND IRENEOfficer12,063$0.37Jun 17, 2026
CHI MICHAEL YChief Operating Officer86,264$N/AJun 15, 2026
ELSHENAWY MOHAMEDChief Technology Officer282,597$N/AJun 15, 2026
BOUGHTON SOLEILOfficer42,261$N/AJun 15, 2026
BECKLUND IRENEOfficer15,971$N/AJun 15, 2026
Page 1 of 16 (153 total transactions)